Gigabecquerel to Terabecquerel

The patient swallows a capsule containing 1–7 GBq of I-131. The thyroid gland concentrates iodine from the bloodstream — it cannot tell radioactive iodine from stable iodine — so the isotope accumulates right where you want it. I-131 emits beta particles with a range of about 2 mm in tissue, which destroy thyroid cells from the inside while sparing nearby structures. The gamma rays it also emits are used for imaging to verify uptake. Within weeks the targeted tissue is dead, no scalpel required.

At 3–7 GBq, a freshly treated thyroid cancer patient is a walking radiation source. They emit gamma rays and excrete I-131 in sweat, saliva, and urine for days. Regulations typically require isolation until the retained activity drops below 1.1 GBq or the dose rate at 1 meter falls below 25 µSv/hr. That usually means 2–5 days of sleeping alone, using a dedicated bathroom, and avoiding prolonged close contact — especially with children and pregnant women, who are more radiation-sensitive.

Brachytherapy places a sealed radioactive source directly inside or next to a tumor — "brachy" is Greek for "short distance." High-dose-rate (HDR) sources of iridium-192 at 100–370 GBq deliver an intense, highly localized dose in minutes. The inverse-square law means tissue just centimeters away receives dramatically less radiation. This precision is why brachytherapy can treat cervical, prostate, and breast cancers with fewer side effects than external beam radiation alone.

Industrial radiography sources (1–20 GBq of Ir-192 or Se-75) live inside heavy shielded containers called "cameras" or "projectors" made of depleted uranium or tungsten. The source is only pushed out through a guide tube during an exposure, and the area is roped off with radiation monitors. Strict transport regulations, tamper-proof locks, and regular inventory audits apply. When sources decay below useful activity, they are returned to the manufacturer. The IAEA maintains a database of lost or orphaned sources — the ones that slip through the system occasionally cause severe accidents.

Diagnostic procedures use just enough activity to produce a readable image — typically 50–800 MBq (0.05–0.8 GBq). The goal is information, not tissue destruction. Therapeutic procedures aim to kill cells, so they use 10 to 100 times more: 1–7 GBq for thyroid ablation, 100–370 GBq for HDR brachytherapy sources. The line between them is roughly 1 GBq. Below that, you are taking a picture; above it, you are prescribing a lethal dose to a very specific target.

The total release from Chernobyl Unit 4 is estimated at 5,200 petabecquerels (5.2 × 10⁶ TBq), though figures vary by source and isotope accounting. Of that, about 1,760 TBq was iodine-131 and 85 TBq was caesium-137. For perspective, the entire global nuclear weapons testing era released roughly 2.6 × 10⁸ TBq — so Chernobyl was devastating but still a fraction of Cold War fallout. Fukushima released about 520 TBq of Cs-137, roughly one-sixth of Chernobyl.

To sterilise food, you need to deliver 1–10 kilograys of absorbed dose in minutes across conveyor belts of product. That requires an enormous photon flux, which only a multi-hundred-TBq cobalt-60 source can provide. A typical facility starts with 500–1,000 TBq and replenishes as the Co-60 decays (5.27-year half-life). The food never becomes radioactive — gamma photons do not induce radioactivity in stable atoms at these energies. Over 60 countries have approved food irradiation for spices, meat, and produce.

Nuclear medicine staff literally call it a "moly cow." A generator arrives with ~150 TBq of Mo-99 adsorbed onto an alumina column. Mo-99 decays (66-hour half-life) into Tc-99m, which is washed off the column with saline — "milking" the generator. Fresh Tc-99m accumulates between milkings, reaching peak yield about every 23 hours. A single generator supplies a hospital for about a week before the parent Mo-99 activity drops too low. It is one of the cleverest supply chains in medicine.

Fresh spent fuel is extraordinarily active — a single assembly registers in the petabecquerel range, dominated by short-lived fission products like I-131, Xe-133, and Ba-140. Within a year, activity drops by about 99% as these burn out. After 10 years it drops another 90%, leaving mainly Cs-137 and Sr-90 (both ~30-year half-lives). After 300 years those are gone too, and the remaining activity comes from transuranics like plutonium — far less active per gram but with half-lives of thousands to millions of years.

Permanently, no — radioactivity decays by definition. Practically, it depends on the isotopes deposited and the cleanup threshold. Chernobyl's exclusion zone still restricts habitation 40 years later because Cs-137 (30-year half-life) contaminated the soil at levels above 1,480 TBq/km² in the worst spots. Parts of Fukushima were decontaminated and reopened within years because the deposition was lower. The real question is not whether an area recovers, but whether society is willing to wait — or pay for aggressive decontamination.